Cybin is assessing CYB004 in the stage 2 scientific trial targeting generalized anxiety disorder. The drugmaker expects to report topline effects from this study in the main 50 % of 2025.Video clips by VICE On the other aspect of the wander-in vault, all around 200kg of vacuum-packed psilocybin mushrooms are stored in boxes that tower all around me